ACCESS Newswire
ACCESS Newswire
More ACCESS Newswire
View Older Stories View Newer Stories-
Halberd and YSU Interviewed on CBS Affiliate WKBN 5pm News as Research Advances
-
Pieris Pharmaceuticals Announces Presentation of Positive Clinical Data for Cinrebafusp Alpa (PRS-343) At 2023 AACR Annual Meeting
-
Ra Medical Electrophysiology Division is Participating in EHRA Congress
-
Karbon-X Corp Retires 27 Tonnes of CO2 in the Name of ATCO Two Rivers From Snow Removal Activites in Northeast British Columbia
-
Simpalm Helps Chicago-Based Company to Launch a Digital Reward Platform for Gaming Cafes
-
Forward Water Technologies Announces Cash for Contract with Global One Media
-
Emergent Metals Corp. Intersects 19.96 g/t Gold and 5.13 g/t Silver over 1.1 Meters at Its Trecesson Property, Quebec
-
HanchorBio Announces US IND Clearance for the Multi-Regional Clinical Trial of HCB101 to Treat Solid and Hematological Malignancies
-
First High-School Education Group Announces Fiscal Year 2022 Unaudited Financial Results
-
Abasca Resources Completes 2023 Winter Drill Program on Key Lake South Uranium Project, Intersecting Anomalous Radioactivity
-
Nextech3D.ai Provides Earnings Call Details for Fiscal Year 2022 and Q4 2022 Financial Results April 20th
-
Usha Resources Provides Reminder of the April 21, 2023 Ex-Distribution Date and Due Bills Trading for the Spin-Out of Formation Metals Inc.
-
Charah Solutions, Inc. Enters Definitive Agreement to be Acquired by SER Capital Partners for $6.00 per Common Share
-
Enzolytics, Inc. Announces Execution of Non-Binding Term Sheet with the Special Purpose Acquisition Company Sagaliam Acquisition Corp. and Updates the Progress on the African Project
-
Laser Photonics Announces Fourth Quarter and Full-Year Fiscal 2022 Results
-
Texas Health Information Exchange, C3HIE Developed Transitional Care Management Dashboard With CrossTx
-
CIBT Announces Change of Name to Global Education Communities Corp
-
American Track Acquires Universal Rail Services and Establishes North American Rail Solutions
-
BCM Welcomes New Board Member
-
NeoGenomics to Announce First Quarter 2023 Financial Results
-
Ferguson PLC Announces Notice of Dividend Currency Exchange Rate
-
NanoViricides Has Shipped Drug Products for Impending Clinical Trials of NV-CoV-2, Its COVID Drug Candidate
-
Linde Announces First Quarter 2023 Earnings and Conference Call Schedule
-
Empower Clinics Signs Agreement To Conduct Research and Clinical Trials with Dallas, TX Based Medical Center - And Major Milestone With Signing Of Research Services Agreement With First Principal Inve
-
Cerrado Gold Reports Strong Q4 and Full-Year Production, Cashflow and Operating Cost Performance at Its Minera Don Nicolas Mine
-
Cerrado Gold Provides an Update for Its Monte do Carmo Gold Project in Tocatins State, Brazil
-
PelicanCorp Highlights Advances in Technology at the Common Ground Alliance Conference and Expo
-
Firefox Gold Closes Second and Final Tranche Of Non-Brokered Private Placement and Announces Two Warrant Amendments
-
PlanetWatch to Sell Air Quality Data Access to a Leading Italian Air Quality Monitoring Firm
-
Conference Call on Interim Report
-
BioNxt Acquires Commercial Coating and Cutting Equipment to Build Out European Commercial Manufacturing Capacity
-
InterContinental Hotels Group PLC Announces Transaction in Own Shares – Apr 17
-
Atalaya Mining PLC Announces Q1 2023 Operations Update
-
Relief Therapeutics Announces Positive 12-Month Stability Data for Inhaled and Intravenous Preparations of RLF-100
-
Relief Therapeutics Announces Positive 12-Month Stability Data for Inhaled and Intravenous Preparations of RLF-100
-
Relief Therapeutics Announces Positive 12-Month Stability Data for Inhaled and Intravenous Preparations of RLF-100
-
Relief Therapeutics Announces Positive 12-Month Stability Data for Inhaled and Intravenous Preparations of RLF-100
-
Relief Therapeutics Announces Positive 12-Month Stability Data for Inhaled and Intravenous Preparations of RLF-100
-
Relief Therapeutics Announces Positive 12-Month Stability Data for Inhaled and Intravenous Preparations of RLF-100
-
Relief Therapeutics Announces Positive 12-Month Stability Data for Inhaled and Intravenous Preparations of RLF-100
-
Relief Therapeutics Announces Positive 12-Month Stability Data for Inhaled and Intravenous Preparations of RLF-100
-
Relief Therapeutics Announces Positive 12-Month Stability Data for Inhaled and Intravenous Preparations of RLF-100
-
Relief Therapeutics Announces Positive 12-Month Stability Data for Inhaled and Intravenous Preparations of RLF-100
-
Relief Therapeutics Announces Positive 12-Month Stability Data for Inhaled and Intravenous Preparations of RLF-100
-
SouthGobi Announces Primary Listing on the Main Board of the Hong Kong Stock Exchange
-
Healthcare Providers Enable Revenue Cycle Transformation, Improving Financial and Operational Performance With MedeAnalytics
-
Newcastle Plumber Shares Top Plumbing Tips for Autumn Season
-
New Resort-Style Accommodation Villages on the Way for the Pilbara's FIFO Workforce: Here's Everything to Know, According to Experts
-
Decriminalising Cannabis Could Save Australian Taxpayers $850M a Year, Report Finds
-
HeadBox is Getting Venues in Front of the Right Customers With Power Host


